
ABVC BioPharma, Inc. Common Stock
ABVC
ABVC: ABVC BioPharma Inc is a clinical-stage biopharmaceutical company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
moreShow ABVC Financials
Recent trades of ABVC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ABVC's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on ABVC's company Twitter account
Number of mentions of ABVC in WallStreetBets Daily Discussion
Recent insights relating to ABVC
Recent picks made for ABVC stock on CNBC
ETFs with the largest estimated holdings in ABVC
Flights by private jets registered to ABVC